Greg Treston

Profiling adverse respiratory events and vomiting when using propofol for emergency department procedural sedation

Objectives:  To evaluate the rate of adverse respiratory events and vomiting among ED patients undergoing procedural sedation with propofol.

What is the nature of the emergence phenomenon when using intravenous or intramuscular ketamine for paediatric procedural sedation

Objective:  Ketamine has become the drug most favoured by emergency physicians for sedation of children in the ED. Some emergency physicians do not use ketamine for paediatric procedural sedation (PPS) because of concern about emergence delirium on recovery. The present study set out to determine the true incidence and nature of this phenomenon.

Optimization of propofol dose shortens procedural sedation time, prevents resedation and removes the requirement for post-procedure physiologic monitoring.

Objective:  To examine the effect of propofol dosing (total dose and number of doses) on patient sedation time and likelihood of resedation.

Do family members interfere in the delivery of care when present during invasive paediatric procedures in the emergency department

Objective:  To determine whether family members interfere with patient care when present during invasive procedures performed on their children in the ED.

Factors associated with patient-reported procedural memory following emergency department procedural sedation with ketamine and propofol: A prospective cohort of 563 patients: PATIENT-REPORTED MEMORY FOLLOWING KETOFOL SEDATION

To describe the proportion of patients reporting procedural memory following procedural sedation and analgesia (PSA) with ketamine and propofol (KP) administered premixed together (ketofol) or individually (sequential KP) in ED attendees. Identify any clinical or demographic variables associated with procedural memory.